Literature DB >> 20133813

The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.

Frauke Borcherding1, Martin Nitschke, Gheorghe Hundorfean, Jan Rupp, Dorthe von Smolinski, Katja Bieber, Cees van Kooten, Hendrik Lehnert, Klaus Fellermann, Jürgen Büning.   

Abstract

In inflammatory bowel diseases (IBD), intestinal epithelial cells (IECs) are involved in the outbalanced immune responses toward luminal antigens. However, the signals responsible for this proinflammatory capacity of IECs in IBD remain unclear. The CD40/CD40L interaction activates various pathways in immune and nonimmune cells related to inflammation and was shown to be critical for the development of IBD. Here we demonstrate CD40 expression within IECs during active IBD. Endoscopically obtained biopsies taken from Crohn's disease (n = 112) and ulcerative colitis patients (n = 67) consistently showed immunofluorescence staining for CD40 in IECs of inflamed ileal or colonic mucosa. In noninvolved mucosa during active disease, tissue obtained during Crohn's disease or ulcerative colitis in remission and biopsies from healthy controls (n = 38) IECs almost entirely lacked CD40 staining. Flow cytometry and RT-PCR analysis using different intestinal epithelial cell lines (HT29, SW480, and T84) showed IFN-gamma to effectively induce CD40 in IECs. Cells were virtually unresponsive to LPS or whole E. coli regarding CD40 expression. In addition, a moderate induction of CD40 was found in response to TNF-alpha, which exerted synergistical effects with IFN-gamma. CD40 ligation by CD40L-transfected murine fibroblasts or soluble CD40L increased the secretion of IL-8 in IFN-gamma pretreated HT29 cells. Our findings provide evidence for the epithelial expression and modulation of CD40 in IBD-affected mucosa and indicate its involvement in the proinflammatory function of IECs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133813      PMCID: PMC2843472          DOI: 10.2353/ajpath.2010.090461

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.

Authors:  Keqiang Chen; Jian Huang; Wanghua Gong; Lingzhi Zhang; Peichu Yu; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2006-06       Impact factor: 11.530

Review 2.  The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; I R Sanderson; H C Reinecker
Journal:  Inflamm Bowel Dis       Date:  1998-02       Impact factor: 5.325

Review 3.  The role of CD40 ligand in costimulation and T-cell activation.

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Rev       Date:  1996-10       Impact factor: 12.988

Review 4.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

5.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.

Authors:  E Battaglia; L Biancone; A Resegotti; G Emanuelli; G R Fronda; G Camussi
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

Review 7.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

8.  Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H Wagner; M Hess; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.

Authors:  M Roy; A Aruffo; J Ledbetter; P Linsley; M Kehry; R Noelle
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

10.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes.

Authors:  P Garrone; E M Neidhardt; E Garcia; L Galibert; C van Kooten; J Banchereau
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  23 in total

1.  CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength.

Authors:  Lorna W Harries; Luke C Pilling; L Dena G Hernandez; Rachel Bradley-Smith; William Henley; Andrew B Singleton; Jack M Guralnik; Stefania Bandinelli; Luigi Ferrucci; David Melzer
Journal:  Aging Cell       Date:  2012-01-13       Impact factor: 9.304

2.  Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.

Authors:  Lillian Maggio-Price; Audrey Seamons; Helle Bielefeldt-Ohmann; Weiping Zeng; Thea Brabb; Carol Ware; Mingzu Lei; Robert M Hershberg
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

Review 3.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice.

Authors:  Jiabin Yan; Zuliang Jie; Lifei Hou; Joao L Wanderley; Lynn Soong; Shalini Gupta; Suimin Qiu; Tehsheng Chan; Jiaren Sun
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

Review 5.  Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Authors:  Evangelos Voudoukis; Konstantinos Karmiris; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

6.  The involvement of the CD40-CD40L pathway in activated platelet-induced changes in HUVEC COX-2 and PPARα expression.

Authors:  Yan-qing Wu; Xiao-shu Chen; Jun-bing Chai
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

7.  Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Authors:  M-A Jenabian; M Patel; I Kema; K Vyboh; C Kanagaratham; D Radzioch; P Thébault; R Lapointe; N Gilmore; P Ancuta; C Tremblay; J-P Routy
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

8.  Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease.

Authors:  Amanda K Huber; Fred D Finkelman; Cheuk Wun Li; Erlinda Concepcion; Eric Smith; Eric Jacobson; Rauf Latif; Mehdi Keddache; Weijia Zhang; Yaron Tomer
Journal:  J Immunol       Date:  2012-08-10       Impact factor: 5.422

9.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

10.  Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.

Authors:  R Hontecillas; W T Horne; M Climent; A J Guri; C Evans; Y Zhang; B W Sobral; J Bassaganya-Riera
Journal:  Mucosal Immunol       Date:  2010-11-10       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.